Skip to main content
Clinical Trials/CTRI/2019/12/022267
CTRI/2019/12/022267
Not yet recruiting
Phase 4

Comparison of the efficacy, safety and cost effectiveness of minocycline hydrochloride extended release versus minocycline in moderate to severe non-nodular facial acne vulgaris: A Randomised , parallel, open label, prospective study

Government Medical College0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: L700- Acne vulgaris
Sponsor
Government Medical College
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Subjects with inflammatory, non nodular moderate to severe facial acne vulgaris
  • 2\.Subjects between 12\-18 years of age, written assent will be taken.
  • 3\.Subjects of either gender.
  • 4\.Subjects willing to give written informed consent.

Exclusion Criteria

  • 1\. Subjects with more than 2 nodules or cysts on the face,
  • 2\. Subjects with acne conglobata, acne fulminans, secondary acne (chloracne, drug\-induced acne, etc.),
  • 3\. Female Subjects who are pregnant, nursing or planning a pregnancy during the study.
  • 4 Subjects with known or suspected allergy to one of the investigational products.
  • 5\. Subjects with history of liver \& kidney disorder.
  • 6\. Subjects on anticoagulants, antacids, iron tablets..
  • 7\. Subjects with history of autoimmune disorder.

Outcomes

Primary Outcomes

Not specified

Similar Trials